Search alternatives:
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), a decrease (Expand Search)
-
1
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
2
-
3
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
4
-
5
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
6
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”
-
7
-
8
-
9
-
10
Risk of bias summary.
Published 2025“…The observed decrease in body weight could be partially attributed to factors influencing energy balance, as evidenced by the significantly lower mean calorie intake at the end of the intervention (1694.71 kcal/day, 95% CI: 1498.57–1890.85) compared to the baseline intake (2000.64 kcal/day, 95% CI: 1830–2172.98), despite the absence of intentional efforts to restrict energy intake by the participants. …”
-
11
Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis.
Published 2025Subjects: -
12
-
13
-
14
-
15
-
16
Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.
Published 2025Subjects: -
17
-
18
-
19
-
20
Means with standard errors across time points for the outcome of social distance.
Published 2024Subjects: